[HTML][HTML] Implant based breast reconstruction with acellular dermal matrix: safety data from an open-label, multicenter, randomized, controlled trial in the setting of …

F Lohmander, J Lagergren, PG Roy, H Johansson… - 2019 - journals.lww.com
Objective: To evaluate clinical outcomes of using acellular dermal matrix (ADM) with implant
based breast reconstructions (IBBRs) in a randomized controlled trial. Summary Background …

Early complications and implant loss in implant-based breast reconstruction with and without acellular dermal matrix (Tecnoss Protexa®): a comparative study

S Potter, A Chambers, S Govindajulu, A Sahu… - European Journal of …, 2015 - Elsevier
Introduction Acellular dermal matrix (ADM) may improve outcomes in implant-based breast
reconstruction, but recent evidence suggests complication rates may be higher when ADM is …

Effect of immediate implant-based breast reconstruction after mastectomy with and without acellular dermal matrix among women with breast cancer: a randomized …

F Lohmander, J Lagergren, H Johansson… - JAMA network …, 2021 - jamanetwork.com
Importance The use of acellular dermal matrix (ADM) in implant-based breast
reconstructions (IBBRs) is established practice. Existing evidence validating ADMs …

Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix …

REG Dikmans, VL Negenborn, MB Bouman… - The Lancet …, 2017 - thelancet.com
Background The evidence justifying the use of acellular dermal matrices (ADMs) in implant-
based breast reconstruction (IBBR) is limited. We did a prospective randomised trial to …

Updated evidence of acellular dermal matrix use for implant-based breast reconstruction: a meta-analysis

KT Lee, GH Mun - Annals of surgical oncology, 2016 - Springer
Background Although the use of acellular dermal matrix (ADM) has increased exponentially,
debates regarding its safety are still ongoing. There have been several meta-analyses; …

Systematic review and critical appraisal of the impact of acellular dermal matrix use on the outcomes of implant-based breast reconstruction

S Potter, D Browning, J Savović… - Journal of British …, 2015 - academic.oup.com
Background Acellular dermal matrix (ADM) may improve outcomes in implant-based breast
reconstruction (IBBR). The aim of this study was critically to appraise and evaluate the …

Acellular dermal matrices in breast reconstruction: CARE trial 5-year outcomes data for more than 9500 patients

WA Ellsworth IV, J Hammer, L Luo… - … Surgery–Global Open, 2022 - journals.lww.com
Background: Few studies have assessed long-term complications in women undergoing
implant-based breast reconstruction with use of an acellular dermal matrix (ADM). This study …

Quality of life and patient satisfaction after implant-based breast reconstruction with or without acellular dermal matrix: randomized clinical trial

F Lohmander, J Lagergren, H Johansson, PG Roy… - BJS open, 2020 - academic.oup.com
Background Acellular dermal matrix (ADM) in implant-based breast reconstructions (IBBRs)
aims to improve cosmetic outcomes. Six-month data are presented from a randomized trial …

The Multi Centre Canadian Acellular Dermal Matrix Trial (MCCAT): study protocol for a randomized controlled trial in implant-based breast reconstruction

T Zhong, C Temple-Oberle, S Hofer, B Beber, J Semple… - Trials, 2013 - Springer
Background The two-stage tissue expander/implant (TE/I) reconstruction is currently the gold
standard method of implant-based immediate breast reconstruction in North America …

Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction …

VL Negenborn, DA Young-Afat, REG Dikmans… - The Lancet …, 2018 - thelancet.com
Background There is increasing interest in the use of acellular dermal matrices (ADMs) in
implant-based breast reconstruction (IBBR). Suggested advantages are that ADMs facilitate …